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Radial glial cells and astrocytes function to support the construction
and maintenance, respectively, of the cerebral cortex. However, the
mechanisms that determine how radial glial cells are established,
maintained, and transformed into astrocytes in the cerebral cortex are
not well understood. Here, we show that neuregulin-1 (NRG-1) exerts
a critical role in the establishment of radial glial cells. Radial glial cell
generation is significantly impaired in NRG mutants, and this defect
can be rescued by exogenous NRG-1. Down-regulation of expression
and activity of erbB2, a member of the NRG-1 receptor complex, leads
to the transformation of radial glial cells into astrocytes. Reintroduc-
tion of erbB2 transforms astrocytes into radial glia. The activated form
of the Notch1 receptor, which promotes the radial glial phenotype,
activates the erbB2 promoter in radial glial cells. These results suggest
that developmental changes in NRG-1–erbB2 interactions modulate
the establishment of radial glia and contribute to their appropriate
transformation into astrocytes.
Radial glial cells play a critical role in the construction of themammalian brain by contributing to the formation of neurons
and astrocytes and providing an instructive scaffold for neuronal
migration (1–7). The establishment of radial glial cells from an
undifferentiated sheet of neuroepithelium precedes the generation
and migration of neurons in the cerebral cortex. During early stages
of corticogenesis, radial glial cells can give rise to neurons (3–5).
Subsequent neuronal cell movement in the developing mammalian
cerebral cortex occurs mainly along radial glial fibers, although
nonpyramidal neurons initially migrate into the cortex in a radial
glial-independent manner (1, 2, 4–7).
During late stages of corticogenesis, as neurogenesis and
migration dwindles, the radial glial scaffolding in the telenceph-
alon is dismantled and transformed into type 1 astrocytes (8–10).
Astrocytes contribute to the emergence and maintenance of
mature brain circuitry through their function as modulators of
neuronal activity (11), neurogenesis (12), and as potential neu-
ronal precursors (13). Neurodevelopmental disorders affecting
the development of radial glial cells lead to faulty neuronal and
glial differentiation, thus resulting in gross CNS malformations
characterized by neuronal misplacement and connectivity (14).
Despite their significance, the molecular signals controlling the
establishment, maintenance, and transformation of radial glial
cells in the developing cerebral cortex are poorly defined.
Neuregulin-1 (NRG-1), a member of the NRG family of
proteins, has been implicated in the differentiation of glial cells
from both central and peripheral nervous systems (15, 16). In the
developing CNS, NRG-1 is expressed in migrating neurons and
oligodendrocyte precursors and is thought to positively influence
radial glial cell function and oligodendrocyte development (17–
21). NRG-1 mediates its effects via the activation of dimers of
protein tyrosine kinase receptors, erbB2, erbB3, and erbB4. All
three of these receptors are expressed in cerebral cortex during
radial glial development (17, 22, 23). We thus sought to deter-
mine whether NRG-1-mediated signaling is involved in radial
glial cell development and differentiation in the cerebral cortex.
We show that NRG-1 signaling, involving erbB2, may act in
concert with Notch signaling to exert a critical influence in the
establishment, maintenance, and appropriate transformation of
radial glial cells in cerebral cortex.
Materials and Methods
Clonal Analysis to Study NRG’s Role in the Initial Establishment of
Radial Glial Cells. Embryonic day 9.5 (E9.5) telencepahalic vesicles
from WT and NRG mice (23) were dissociated and cultured
at clonal density (500 cells per well) in eight-well chamber glass
coverslides in neurobasalN2B27 medium. To test the influence of
NRG-1, duplicate cultures were supplemented with 50 ngml
NRG-1 [rhNRG-1 (glial growth factor 2); CeNes]. Location of
single, isolated cells were noted 6 h after plating. After 6 days in
vitro, cultures were fixed and colonies from single cells were labeled
with neuron-specific TuJ-1 and radial glial-specific RC2 antibodies.
The total number of clonal colonies present were counted for each
experimental condition. Each of the colonies was assigned to one
of three groups: colonies containing radial glia and other neural
cells, colonies containing only radial glial cells, and colonies con-
taining no radial glial cells. The number of radial glial cells in each
group was also counted. Similarly, neuronal cells in clones were
screened with TuJ-1 immunoreactivity. Results were from inde-
pendent experiments with five different litters.
Explant Assays to Study NRG-1’s Effect on Radial Glial Development.
E9.5 telecephalic vesicles from WT and NRG-1 mice were
sectioned into 50-m-thick slices and cultured in MEM10% FBS
on poly-D-lysine-coated dishes for 4 days. Explants were fixed,
immunolabeled with anti-RC2 and TuJ-1 antibodies, and nuclear-
counterstained with bis benzimide. The ratio of RC2 or TuJ-1
cells per number of total cells emigrated from explants (i.e., cell
index) was quantified by placing the explants at the center of a
500  500-m grid and calculating the total number of cells and
RC2 or TuJ-1 cells in the grid. Results were from independent
experiments with three separate litters. WT and  E9.5 telen-
cephalon from five different litters were used to analyze RC2
labeling in vivo.
RT-PCR. RT-PCR was carried out with the Superscript OneStep
RT-PCR system (Invitrogen) using equal amounts of total RNA
from E9.5–10 telencephalon. Each set of reactions was repeated
thrice with RNA from different litters. See Supporting Text, which
is published as supporting information on the PNAS web site,
www.pnas.org, for details on primers and cycle parameters used.
Abbreviations: DN, dominant negative; En, embryonic day n; GFAP, glial fibrillary acidic
protein; NICD, Notch intracellular domain; NRG, neuregulin.
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Luciferase Assays. E10.5 radial glia were cultured in neurobasalB27
medium and FGF2 (20 ngml), at a density of 50,000 cells per cm2
on polyornithine-laminin-coated plates. The next day, the cells were
transfected with Notch intracellular domain (NICD), Nbl, ErbB2-
luc, WT erbB2 pal-luc, or mut erbB2 pal-luc by using the calcium-
phosphate method. The cells were harvested 48 h later, and
luciferase activity was measured by using the Dual Luciferase
Reporter Assay (Promega; ref. 24). See Supporting Text for details
on the assay and gene constructs used.
Antibodies and ErbB2 Receptor Constructs. Full-length and truncated
erbB2 constructs were obtained from D. Stern (Yale University;
ref. 25). The truncated erbB2 was subcloned into pEGFP-N3 vector
(CLONTECH) to generate the dominant negative (DN) erbB2-
GFP plasmid. Full-length erbB2 was subcloned into pEGFP-N3
and pIRES-EGFP vectors (CLONTECH). The identities of these
constructs were confirmed by sequencing. See Supporting Text for
details on the list and source of antibodies used.
Generation and Analysis of Glial Fibrillary Acidic Protein (GFAP)
Promoter–DNerbB2-GFP Mice. hGFAP promoter–DNerbB2-GFP
transgene was used for pronuclear microinjection of fertilized eggs
from FVBN strain mice. For details on transgene construction and
PCR or Southern blotting analysis of founder mice, see Supporting
Text.
To analyze transgene expression in hGFAP–DNerbB2-GFP
mice, cortices of E16 embryos were homogenized in 0.15 mM
NaCl0.05 mM TrisHCl, pH 7.21% Triton X-1001% sodium
deoxycholate0.1% SDS, immunoprecipitated with anti-GFP an-
tibodies (Sigma), and immunoblotted with anti-GFP antibodies to
detect the expression of GFP-tagged DNerbB2.
To assay the effect of DNerbB2 expression on tyrosine phos-
phorylation of erbB2 in hGFAP–DNerbB2-GFP mice, E16 cortical
cells were challenged with NRG-1, and the phosphorylation status
of erbB2 was evaluated in immunoprecipitationblotting assays.
See Supporting Text for details.
Bioassays. To assay the role of erbB2 receptors in radial glial
development, radial glial cell cultures were established from E15
mouse cerebral cortices (17), plated at a density of 10,000 cells per
well (eight-well chambers), and transfected with DNerbB2-GFP
plasmid or GFP plasmid with Lipofectamine (GIBCO). After 48 h
in neurobasalN2 medium supplemented with NRG-1 (50 ngml),
cells were fixed and labeled with RC2 or anti-GFAP antibodies.
Radial glia and astrocytes were defined by their unique morphology
and antigenic marker expression. RC2 radial glial cells are
unipolar or bipolar cells with elongated, pear-shaped cell soma and
long, slender processes (50 m). In contrast, anti-GFAP astro-
cytes display a flat, stellate shape. Radial glial and astrocyte cells
that are positive for both the reporter GFP and glial markers were
quantified. Cells that are immunoreactive with both RC2 and
anti-GFAP antibodies (8  2.2% of astroglial population in vitro)
generally have the multipolar morphology of astrocytes and are
counted as astrocytes.
In separate assays, using radial glial cells from E16 rat cortices
(plating density  10,000 cells per well), erbB2 function was
inhibited with anti-erbB2 receptor-specific mAb 7.6.4. As control,
a mAb of the same isotype (Ig2A) was used. After 36 h of incubation
in 10 gml affinity-purified antibodies plus 50 ngml NRG-1,
cultures were fixed in 4% paraformaldehyde and labeled with rat
astroglial-specific rat-401 antibodies. Radial glial and astrocyte cell
numbers were quantified by using the METAMORPH system (Uni-
versal Imaging, Media, PA).
Mature astrocytes from 4-week-old mice were cultured at low
density (5,000 cells per well; 16-well chambers) as described (16)
and transfected with erbB2-GFP or GFP plasmids. After 48 h in
vitro in neurobasalN2 medium plus NRG-1 (50 ngml), GFP-
expressing cells that are positive for GFAP or RC2 were quantified
as described. Quantitative analysis of the above bioassays were
based on four to seven independent experiments.
To assay glial cell proliferation, 10 m of BrdUrd was added to
cultures 24 h before fixation and immunolabeling with anti-BrdUrd
(Becton Dickinson) and GFAP or RC2 antibodies. Changes in cell
death were measured by using terminal deoxynucleotidyltrans-
ferase-mediated dUTP end labeling assay (Roche Molecular
Biochemicals).
Results
Role of NRG-1-Mediated Signaling in the Establishment of Radial Glial
Cells. NRG-1 is expressed in the ventricular neuroepithelial cells,
before the appearance of radial glial cells (Fig. 1 a and b). If NRG-1
is critical for the establishment of radial glia, the absence of NRG-1
should lead to altered radial glial development. To test this possi-
bility, neuroepithelial cells from E9.5 telencephalic vesicles from
WT and NRG-deficient mice were dissociated and plated at clonal
density. Isolated cells were marked and allowed to proliferate, and
after 6 days, the cellular composition of individual clones, generated
from WT and NRG-efficient neuroepithelial cells, was analyzed
(Fig. 1c). Eighty-six percent of the clones from WT neuroepithelial
cells contained RC2-positive cells. In contrast, only 45% of the
clones were RC2 positive in the absence of NRG (Fig. 1d). The
percentage of RC2-positive cells per clone was also reduced in
NRG mutants (WT, 43  6%; , 28  9%). Purely RC2-
positive clones were not generated from NRG-deficient neuroep-
Fig. 1. NRG-1 promotes radial glial
cell establishment. (a and b) Expression
of NRG-1 in WT (a) and NRG (b)
E.9.5 telencephalon immunolabeled
with anti-NRG1 antibodies. (c–e) Iso-
lated neuroepithelial cells from WT and
NRG telencephalic vesicles were
cultured at clonal density for 6 days. (c)
Clones devoid of RC2-positive cells,
clones containing some RC2-positive
cells, and clones entirely made of RC2-
positive cells were identified. (d) Signif-
icant reduction in the number of RC2
cell-containing clones was noticed in
the absence of NRG-1. This deficit was
rescued by the addition of exogenous
NRG-1. (e) No changes in the genera-
tion of neuronal cells were noticed in
NRG mice. ( f ) RT-PCR analysis of
Hes1 and neurogenin expression in E9.5 WT and NRG telencephalon. (g) RC2-positive processes of radial glial cells in E9.5 WT telencephalon. (h) Impaired
RC2 labeling in littermate NRG telencephalon. Data shown are mean  SEM; *, P  0.01, Student’s t test. (Scale bar: a, b, g, and h, 10 m; c, 20 m.)
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ithelial cells (WT, 10.5  6%; , 0%; Fig. 1d). The average
numbers of cells per clone from WT and NRG mutant neuroep-
ithelial cells were not significantly different (WT, 5.52  1.26%;
, 4.3  0.44%). The deficit in the establishment of RC2-
positive radial glial cells in the absence of NRG can be rescued by
the addition of exogenous NRG-1 to the NRG-deficient telence-
phalic neuroepithelial cells. In the presence of NRG-1, 82% of the
clones were RC2 positive and the percentage of RC2-positive cells
per clone was 42%, similar to that of WT cells (Fig. 1d).
To determine the specificity of the NRG effect on radial glial
development, we tested the generation of neurons in these clones
with a neuron-specific marker (TuJ-1). No significant difference
was noticed in TuJ-1-positive clones between WT and NRG-1
mutant cells (WT, 77  13.3%; , 76.4  12.3%), suggesting
that NRG’s effect is particular to the radial glial cell lineage and
does not significantly influence early neuronal generation (Fig. 1e).
In addition to RC2, radial glial cells can be identified with
markers such as brain lipid binding protein (BLBP) and glutamate
transporter (GLAST). Compared with untreated controls, expo-
sure to NRG-1 increased the number of BLBP- and GLAST-
positive radial glial cells by 84  11% and 70  17%, respectively.
To further analyze the role of NRG-1 in the establishment of
radial glial cells, E9.5 telencephalic vesicles were removed from WT
and NRG mice and cultured for 4 days, before immunolabel-
ing with RC2 and neuron-specific Tuj1 antibodies. Both radial glial
cells and neurons emigrated from WT explants, but 72  3.8%
fewer RC2-positive cells were generated from NRG explants
(Fig. 2). Neuronal generation appears not to have been significantly
affected in NRG explants. In vivo, in WT E9.5 telencephalon,
RC2 labels strands of radial glia cell fibers (arrows, Fig. 1g), in
agreement with previous studies (26). In contrast, a significant
dearth of RC2 cells was noticed in NRG mutant telencephalon
(Fig. 1 g and h).
Because several basic-helix–loop–helix (bHLH) transcription
factors are known to differentially influence neurogenesis and
gliogenesis in the CNS, we next examined the effect of NRG-1 on
transcription factors known to influence gliogenesis. The bHLH
factor Hes1 plays a role in gliogenesis, whereas neurogenin 1
positively regulates neuronal differentiation (27, 28). Hes1 also
functions as an effector gene for Notch signaling, which is critical
in the generation of radial glial cell identity (29). RT-PCR analysis
of Hes1 expression in telencephalon of E9.5 WT and NRG
mice indicated a lack of Hes1 expression in NRG neuroepi-
thelial cells. In contrast, neurogenin 1 was expressed normally in
NRG cells (Fig. 1f).
Together, these results suggest that NRG-1 plays a crucial role in
the initial establishment of the radial glial cell scaffold before the
onset of neuronal migration and layer formation in cerebral cortex.
Expression of ErbB2, ErbB3, and ErbB4 Receptors in Radial Glial Cells
and Astrocytes. To map the distribution of erbB receptors during
radial glial development freshly isolated embryonic cortical radial
glia and mature cortical astrocytes were coimmunolabeled with
affinity-purified anti-erbB antibodies and radial glial-specific RC2
or astrocyte-specific anti-GFAP antibodies, respectively. Radial
glial cells are immunoreactive for erbB2, erbB3, and erbB4 (Fig. 3).
In contrast, astrocytes from mature cerebral cortex primarily ex-
press erbB3 and erbB4 and significantly down-regulate erbB2
expression (Fig. 3).
The decrease in erbB2 expression, between E18 and P0, coin-
cides with the radial glia to astrocyte transformation in the devel-
oping cerebral cortex (17, 22). We hypothesize that NRG-1 signal-
ing involving the erbB2 receptor is crucial for the maintenance and
function of radial glial cells during the early phases of cortical
development. Down-regulation of this receptor and accompanying
changes in NRG-1-induced signaling cascades may then trigger the
Fig. 2. Lack of NRG impairs radial glial cell generation. Explant cultures of
telencephalon from E9.5 WT and NRG mice were immunolabeled with RC2
(a and c) or TuJ-1 (e and f ) antibodies. Compared with WT (a and b), significantly
fewer RC2-positive cells were generated from NRG explants (c, d, and g). Bis
benzimide nuclear counterstain (b and d) indicates that deficiency in RC2 cells
in NRG explants is not caused by general lack of cell generation. Neuronal
generation was not affected in NRG explants (e, WT; f, ; and g). (g)
Number of radial glial or neuronal cells per total number of cells was calculated
for each explant and used as cell index. Results from NRG mice were nor-
malized to measurements from littermate WT controls. Data shown are mean 
SEM; *, P  0.01, Student’s t test. (Scale bar: 60 m.)
Fig. 3. Distribution of erbB receptors in radial glia and astrocytes. Embryonic
radial glial cells (E15) and mature astrocytes (4 weeks) in culture were immuno-
stained with polyclonal antibodies to erbB2 (a and b), erbB3 (c and d), and erbB4
(e and f ). Radial glial cells and astrocytes were colabeled with RC2 and anti-GFAP
antibodies, respectively. All erbB receptors are expressed in radial glia, whereas
only erbB3 and erbB4 are highly expressed in astrocytes. (Scale bar: 60 m.)








transformation of radial glia into astrocytes at the appropriate
developmental stages during corticogenesis.
Role of ErbB2 Receptors in the Transformation of Radial Glial Cells into
Astrocytes. To determine whether signaling involving erbB2 recep-
tors plays a role in the maintenance and transformation of radial
glial cells, we first blocked the radial glial cell surface expression and
function of erbB2 with an affinity-purified mAb to erbB2, 7.6.4 (30).
After 36 h in vitro, the distribution of radial glial and astrocyte cell
populations was assessed by morphology and rat-401 immunoflu-
orescence. Radial glial cells are unipolar or bipolar cells with
elongated, pear-shaped cell soma and long, slender processes. In
contrast, astrocytes display a flat, stellate shape. Blocking of erbB2
receptors on the radial glial cell surface led to the transformation
of radial glial cells into astrocytes (Fig. 4). A greater proportion of
glial cells cultured in the presence of anti-erbB2 antibodies ex-
pressed astrocyte morphology (radial gliaastrocyte  21 
4%:79  3%), whereas the cells cultured under control conditions
were mainly of radial glial phenotype (radial gliaastrocyte  71 
4%:28  3%). These results support the hypothesis that signaling
involving erbB2 receptors is crucial for the maintenance of radial
glial cells and in the absence of erbB2 signaling radial glial cells
transform into astrocytes.
To further test this idea, radial glial cells from E15 mouse cortices
were transfected with DNerbB2-GFP or control GFP plasmids. The
DNerbB2 receptor lacks the intracellular domain, including ty-
rosine kinase and phosphorylation sites, and thus does not trans-
duce signals upon interactions with NRG-1. Expression of
DNerbB2 in C6 glioma cells resulted in the inhibition of NRG-1-
induced phosphorylation of erbB receptors (185 kDa). DNerbB2-
GFP or GFP-transfected cells were maintained for 48 h in NRG-1
and then labeled with radial glial-specific RC2 and astrocyte-
specific anti-GFAP antibodies. Transfected cells that were positive
for GFP and glial markers were counted according to their phe-
notype. Glial cells expressing DNerbB2-GFP were mainly of astro-
cyte phenotype (radial gliaastrocyte ratio  13.5  2.1:85.65  2).
Cells transfected with control plasmids were mainly of radial glial
phenotype (radial gliaastrocyte ratio  70.31  3:29.7  3.34; Fig.
4). Cell death and cell division dynamics of DNerbB2 and GFP-
transfected cells were analyzed with terminal deoxynucleotidyl-
transferase-mediated dUTP end labeling and BrdUrd incorpora-
tion, respectively. Expression of DNerbB2 or GFP did not
specifically affect the survival or division of embryonic cortical cells
(Table 1, which is published as supporting information on the PNAS
web site).
To test whether down-regulation of erbB2 receptor function
triggers the transformation of radial glia into astrocytes in vivo,
transgenic mice expressing DNerbB2 under the control human
GFAP promoter were generated. Previous studies indicate that this
promoter can drive gene expression in radial glia as early as E13
(31). A transgene encoding DNerbB2 linked to the GFP gene under
the control of GFAP promoter was constructed and used for
pronuclear microinjection (Fig. 5a). Seven founder lines were
identified by Southern blot analysis of tail DNA and independent
breeding lines were established from two (named DN-1 and DN-2;
Fig. 5b). Immunoblotting and immunohistochemical analysis of
embryonic cortices of these lines with anti-GFP antibodies indi-
cated that the DNerbB2-GFP transgene was expressed in the
developing cortex in astroglial cells (Fig. 5 c and j). Expression of
DNerbB2 significantly attenuated NRG-1-induced phosphoryla-
tion of erbB2 receptors in these cortices (Fig. 5d). To analyze the
effect of DNerbB2 expression on radial glial development in vivo,
E16 cortices of DNerbB2 mice were removed and labeled with
anti-GFAP antibodies. At E16, in WT cortices, only occasional
GFAP-positive cells, primarily associated with blood vessels were
noticed (Fig. 5 e–g). However, in both transgenic lines, a significant
increase in GFAP-positive astroglial cells was evident in the de-
veloping cerebral wall (Fig. 5 h–k). Both multipolar astrocytes
(arrows, Fig. 5h) and elongated, branching cells, characteristic of
transforming radial glia (arrowheads, Fig. 5h) were seen. Both
transgenic lines expressed similar patterns of premature radial glial
differentiation, indicating the insertion site independent effect of
DNerbB2 transgene. Taken together, these data suggest that down-
regulation of erbB2 activity in radial glia leads to premature
transformation of these cells into GFAP-positive astroglia in the
developing cerebral wall. Regional differences in aberrant radial
glial development, the overall effect on cortical patterning, and
effects on neuronal or oligodendrocyte differentiation in these lines
remains to be characterized.
Fig. 4. Radial glia transform into astrocytes in the absence of signaling via
erbB2, and erbB2 expression induces astrocyte to radial glia transformation. (a–c)
Radial glial cells (E16) were cultured in the presence of anti-erbB2 mAb (b) or
control (a) antibodies. Under control conditions, 71  4% cells were radial glial
cells (arrow, a); the rest were astrocytes (28  3%). However, when erbB2 was
blocked, only 21  4% of the cells were of radial glial phenotype and 79  3% of
cells displayed the transformed phenotype of astrocytes (arrow, b; c). Cells were
labeled with rat-401 antibodies. Data shown are mean  SEM. (Scale bar  30
m.) (d)C6cellsweretransfectedwitherbB2-GFP,GFP,orDNerbB2-GFPplasmids,
treated with 50 ngml NRG-1 for 10 min, and immunoblotted with antiphospho-
tyrosine or acetylated tubulin antibodies. DNerbB2 drastically reduced NRG-1-
induced tyrosine phosphorylation of ErbB receptors (185 kDa). (e–i) Radial glia
from E15 mouse cortices were transfected with DNerbB2-GFP (e and f ) or control
GFP(gandh)plasmids.After48h,cells thatarepositiveforGFPandtheradialglial
(RC2-blue; e and f ) or astrocyte markers (anti-GFAP-red; g and h) were counted
according to their phenotype. Glial cells expressing DNerbB2-GFP were mainly of
astrocyte phenotype (radial gliaastrocyte ratio  13.5  2.1:85.65  2; e, f, and
i). Cells transfected with control plasmids were mainly of radial glial phenotype
(radial gliaastrocyte ratio  70.31  3:29.7  3.34; g–i). (Scale bar  30 m.) ( j–p)
Mature astrocytes from 4-week-old mouse cortices were transfected with GFP ( j
and k) or erbB2-GFP (l–o) plasmids. After 48 h, GFP-positive cells labeled with
anti-GFAP (k and m; red) or RC2 (o; blue) antibodies were quantified. Cells
expressing erbB2 were predominantly of radial glial phenotype (percentage of
glial cells that are radial glia: GFP, 14  4.6, erbB2-GFP, 65.7  5.9), whereas cells
transfected with GFP were mainly astrocytes (percentage of glial cells that are
astrocytes: GFP, 85.3  4.5; erbB2-GFP, 34.2  6). (Scale bar  30 m.)
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Transformation of Astrocytes into Radial Glial Cells. To determine
whether ectopic reexpression of erbB2 in mature astrocytes can
induce them to revert to radial glial phenotype, mature astrocytes
from 4-week-old mice cortices were transfected with GFP or
erbB2-GFP, and the phenotypes of the GFP-positive transfected
cells were monitored after 48 h with radial glial- and astrocyte-
specific markers. The percentage of radial glial cells increased
significantly after erbB2 expression (GFP 14  4.6; erbB2-GFP
65.7  5.9), whereas cells expressing control GFP were primarily
astrocytes (radial gliaastrocyte ratio  14.7  4.6:85.3  4.5; Fig.
4 j–p). ErbB2-expressing cells of intermediate morphology with
fewer but elongated processes were also noticed (Fig. 4 j–p). These
may represent cells that were in the process of transforming from
astrocyte to radial glial phenotype. Terminal deoxynucleotidyl-
transferase-mediated dUTP end labeling and BrdUrd incorpora-
tion analysis of GFP- or erbB2-GFP-transfected cells indicated no
significant differences between these two groups (see Table 1).
Together, these results indicate that reexpression of erbB2 in
astrocytes can induce them to assume radial glial identity, and loss
of erbB2 activity is a critical step in the transformation of radial glia
into astrocytes.
Transactivation of the ErbB2 Promoter by Activated Notch1 in Radial
Glial Cells. It has recently been shown that development of radial glia
is regulated, in part, by Notch signaling (29, 32). Notch signaling is
activated by binding of the DSL (Delta-Serrate-lag-2) family of
ligands to the extracellular domain of Notch, releasing the intra-
cellular domain, which can then migrate to the nucleus and regulate
gene expression in concert with the CSL transcription factor,
RBP-Jk or CBF-1 (33, 34). Truncated forms of Notch that consist
solely of the intracellular domain (NICD) have constitutive signal-
ing activity.
One likely downstream effector of Notch signaling in radial glial
cells is erbB2. Multiple RBP-Jk binding sites have been identified
in the human erbB2 promoter and NICD was shown to increase
transcription of a reporter construct containing erbB2 RBP-Jk
binding sites (35). Notch 1 receptors were expressed in radial glial
cells (Fig. 6a) and both Notch1 and erbB2 were coexpressed in
radial glia (data not shown). Transient transfection of radial glial
cells with NICD was sufficient to activate the WT erbB2 promoter
as well as an erbB2 reporter construct containing intact RBP
binding sites but not a promoter containing mutated sites (Fig. 6).
Furthermore, known inhibitors of Notch signaling, Numblike (Nbl;
refs. 36 and 37) and a DN form of RBP-Jk (DN-RBP-Jk; ref. 29),
were able to block erbB2 promoter activation by NICD (Fig. 6).
Thus, these data demonstrate that the erbB2 promoter responds to
Notch signaling in radial glial cells, suggesting that erbB2 is one of
the effectors for the regulation of radial glial function by Notch
signaling.
Fig. 5. Down-regulation of erbB2
function transforms radial glia into
astrocytes in vivo. (a) The construct
used for the generation of GFAP pro-
moter-DNerbB2-GFP transgenic
mice. (b) Southern blot analysis of
founder mice. Of the seven founder
lines, two (arrowhead) were used to
establish breeding lines named DN1
andDN2. (c)DNerbB2-GFPtransgene
is expressed in the E16 cortices of
DN1 and DN2 mice, but not in non-
transgenic mice. DNerbB2-GFP pro-
tein expression was detected with
anti-GFP antibodies. (d) NRG-1-in-
duced tyrosine phosphorylation of
erbB2 receptors is attenuated in E16
cortical cells fromDN1andDN2mice.
(Upper) Tyrosine phosphorylation of
erbB2. (Lower) ErbB2 protein. (e–g)
Minimal expression of GFAP-positive
astrocytes in WT (E16) cortex. Arrows
point to astrocytes found in associa-
tion with blood vessels (f) or in the
ventricular zone (e). (h–j) Increased
number of GFAP astroglia were
seen in DN1 (h) and DN2 (i and j)
cortices. (Inset) DNerbB2-GFP trans-
gene is expressed in astroglial cells. Transformed astrocytes in cortex (red) also label with anti-GFP antibodies (green). (k) An 17- to 20-fold increase in GFAP cells
was found in DN1 and DN2 cerebral wall. Number of GFAP cells was counted in 10 sections of the cerebral wall from four embryos each of WT, DN1, and DN2. (Scale
bar  e–g, 45 m; h–j, 60 m.)
Fig. 6. Notch1 up-regulates the expression of erbB2 in radial glial cells. (a)
Notch1 (green) is expressed in RC2-positive (red) radial glial cells of the E13.5
mouse cerebral cortex. Nuclei were detected by using bis benzimide (blue). (Scale
bar  10 m.) (b) E10.5 radial glia were transfected with 250 ng per well of erbB2
pro-luc, WT erbB2 pal-luc, or mut erbB2 pal-luc. Cells were also transfected with
500 ng per well of NICD, DN-RBP Jk, or Nbl, where indicated. Transfection of NICD
resulted in a stimulation of the erbB2 pro-luc and the WT erbB2 pal-luc reporter
constructs. Activation of the WT erbB2 promoters was blocked by DN-RBP Jk and
Nbl. No stimulation of the mutant version of the erbB2 promoter that lacks intact
RBP Jk binding sites (mut erbB2 pal-luc) was observed. Data shown are mean 
SEM (n  3). ***, P  0.005, Student’s t test.









As a permissive and instructive scaffold for neuronal migration,
and as precursors of neurons, radial glial cells play an essential
role in the emergence of laminar organization in the mammalian
cerebral cortex. A critical first step in this process is the
establishment of radial glial cells from neuroepithelial cells in the
ventricular zone. The generation of radial glial cells from
neuroepithelial cells is impaired in NRG mutants and this defect
can be rescued with exogenous NRG-1. The generation of radial
glial phenotype and its derivatives is likely to be influenced by a
hierarchy of diverse molecular cues, including ciliary neurotro-
phic factor, bone morphogenetic proteins, brain lipid binding
protein, glutamate transporter, Musashi-1, rax, neurogenin-3,
Hes1, and pax-6 (3, 38–42). The diversity of molecular cues that
contribute to the establishment of radial glial cells is consistent
with the possibility that there are multiresponsive precursors in
the ventricular neuroepithelium. This diversity may also con-
tribute to the generation of heterogeneity of radial glial cells
within different regions of the developing brain.
Radial glial cells in the cerebral cortex may concurrently function
as neuronal precursors and neuronal migratory guides, although the
extent to which this occurs in the entire radial glial population at
different stages of cortical development remains to be determined
(3–5, 43). NRG-1 is known to modulate neuroepithelial cell pro-
liferation and the reciprocal interactions between migrating cortical
neurons and their radial glial guides (17, 18, 44). In the absence of
NRG-1 signaling via erbB2 receptors, radial glial function and
development is abnormal. NRG-1 has been identified as a suscep-
tibility gene for schizophrenia (45), where abnormal generation,
placement, and connectivity of neurons, resulting from aberrant
radial glial development, may play a role in the etiology of the
disease.
Recent studies indicate that Notch 1 signaling promotes the
establishment of radial glial identity (29, 32). Hes1, an effector gene
for Notch signaling, is down-regulated in NRG mutant telenceph-
alon. Furthermore, NICD activates the erbB2 promoter in radial
glial cells. This activation depended on the presence of RBP Jk
binding sites and was sensitive to inhibition by Numblike and a DN
form of RBP Jk. Thus our data suggests that Notch may act to
up-regulate the expression of erbB2 and thus enhance the response
of radial glial cells to NRG signals.
Whether NRG-1 actively biases neuroepithelial cells toward a
radial glial fate at the expense of other cortical cell types remains
to be determined. However, NRG’s effect on Hes1 expression and
the lack of significant effect on neurogenesis in NRG cells
suggests that it may function to influence cortical precursors toward
a glial-restricted or radial glial fate without directly acting on the
generation of cortical neurons.
After the completion of neuronal migration in the cerebral
cortex, radial glial cells transform into astrocytes or ependymal
cells. They contribute to the emergence and maintenance of mature
brain circuitry through their function as potential stem cells and as
modulators of neuronal activity and neurogenesis (11–13). Down-
regulation of erbB2 induces transformation of radial glia into
astrocytes and ectopic expression of erbB2 causes astrocytes to
revert to a radial phenotype. Such bidirectional developmental
potential of radial glial cells and astrocytes also depends on soluble
signals present in embryonic forebrain (10). A developmental
increase in diffusible gliogenic signals is also thought to specify the
generation of astrocytes in cerebral cortex (46–48). The role of
erbB2 receptors in astrocyte development raises the possibility that
cortical glial development is regulated, in part, by modulating the
competence of the precursors to respond to diffusible gliogenic
signals via developmental regulation of signaling receptor expres-
sion (also see Supporting Text).
Studies thus far indicate that radial glial cells exist in several
different functional states: as precursors of neurons, guides for
neuronal migration, and precursors of astrocytes. Similarly, astro-
cytes appear to exist in quiescent, as well as neural stem cell-like
states. Astrocytes can revert to a radial glial-like phenotype and vice
versa, in response to modulation of NRG-erbB2 signals. Functional
induction of erbB2 in mature astrocytes may facilitate their ability
to support cell migration or neurogenesis during ongoing mainte-
nance of neural circuitry in mature CNS. Further characterization
of NRG-erbB2-related mechanisms controlling the different stages
of radial glial and astrocyte development will be essential to
elucidate the role of radial glia and their derivatives in the emer-
gence and maintenance of the cerebral cortex.
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